A space for qualified clinicians, trainees and students from all areas of health care. We will review the current and future situation of neuropsychopharmacology in the world, the new scientific evidence of pharmacological treatments of major psychiatric disorders.
Neuropsychopharmacology gives us a better understanding of the interaction between psychiatric drugs and brain molecules such as serotonin, dopamine, endorphins, glutamate and others.
We will explore mechanisms of action of psilocybin, multiple neurotransmitter modulators, TORch and NMDA receptors; as well as the determinants of efficacy, tolerability and safety of psychotropic drugs.
See you del 23 al 26 de abril del 2026
at Rivera Diamante Acapulco
We have again confirmed national and international speakers, with whom we will review the scientific evidence of new pharmacological treatments for major psychiatric disorders, including novel mechanisms of action and factors determining the efficacy, tolerability and safety of psychotropic drugs.
Médico Psiquiatra | Presidente y Fundador WARMI Mental Health | Presidente APA Hispanic Caucus | Experto en Seguridad, Epidemiología y Salud Pública | Líder Senior en Neurociencia | Conferencista | Defensor de la Salud Mental
Professor of Psychiatry and Pharmacology, University of Toronto, Canada
Professor of Psychiatry and Pharmacology, University of Toronto, Canada
Chairman and Executive Director, Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada
